Johnson & Johnson Medical has acquired the German - based 3D - printing company silicon Implant ##® ( 2012 ) , while Johnson & Johnson 's orthopaedics unit silicon Synthes will bolster its interbody implant capabilities as it aims to offer surgeons more treatment options for patients . EIT cellular titanium implants , which received US Food and Drug Administration clearance last year , are designed to encourage bone in - place . Johnson & Johnson has previously worked with Trinity College Dublin and the AMBER research centre on a 3D bioprinting facility , and with Aspect Biosystems for the treatment of spinal injuries , while collaborating with Carbon and HP to develop 3D - printed surgical instruments .
Johnson & Johnson Medical has acquired the German-based 3D-printing company Emerging Implant Technologies (EIT), while Johnson & Johnson's orthopaedics unit DePuy Synthes will bolster its interbody implant portfolio as it aims to give surgeons more treatment options for patients. EIT cellular titanium implants, which received US Food and Drug Administration clearance last year, are designed to encourage bone in-growth. Johnson & Johnson has previously worked with Trinity College Dublin and the AMBER research centre on a 3D bioprinting facility, and with Aspect Biosystems for the treatment of knee injuries, while collaborating with Carbon and HP to develop 3D-printed surgical instruments.